SCHEMBL20400596

SCHEMBL20400596

FC(F)(F)c1ncccc1CNc1nc(Cl)nc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.56
PDE5A O76074 3/20 0.56
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TLR7 Q9NYK1 1/20 0.43
USP1 O94782 4/20 0.43
WDR48 Q8TAF3 4/20 0.43
CD38 P28907 1/20 0.43
CCNE1 P24864 3/20 0.43
CDK2 P24941 3/20 0.43
CCNE2 O96020 2/20 0.43
JAK2 O60674 1/20 0.42
IGF1R P08069 1/20 0.42
PIM1 P11309 1/20 0.42
SRC P12931 1/20 0.42
CSNK2A2 P19784 1/20 0.42
KCNA5 P22460 1/20 0.42
JAK1 P23458 1/20 0.42
TYK2 P29597 1/20 0.42
FLT4 P35916 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20399075 0.87 CD38 (0.41) APPPDE5AMEN1KMT2ATLR7
SCHEMBL20399092 0.87 PIP4K2C (0.46) APPPDE5AMEN1KMT2ACD38
SCHEMBL21567239 0.83 APP (0.62) APPPDE5AMEN1KMT2AUSP1
SCHEMBL21542064 0.81 BCHE (0.61) APPMEN1KMT2ATLR7CD38
SCHEMBL30092920 0.81 BCHE (0.61) APPMEN1KMT2ATLR7CD38
SCHEMBL26740730 0.80 PDE5A (0.58) APPPDE5AMEN1KMT2AUSP1
SCHEMBL21542053 0.79 TLR7 (0.42) PDE5AMEN1KMT2ATLR7USP1
SCHEMBL30092857 0.79 TLR7 (0.42) PDE5AMEN1KMT2ATLR7USP1
SCHEMBL21567245 0.76 YTHDC1 (0.47) APPPDE5ATLR7USP1WDR48
SCHEMBL20399159 0.76 PIP4K2C (0.55) APPPDE5AUSP1WDR48CD38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2026-02-10 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2022-12-06 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed
WO-2018134685-A2 COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2018-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds CBR1, CBR3, COX6C APP 4837/4885PDE5A 4397/4885MEN1 4872/4885
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS PWWP2B, WARS1, PNPO APP 3897/4885PDE5A 2823/4885MEN1 4437/4885
US-20190345157-A1 COMPOUNDS ABCB11, LTC4S, AQP1 APP 2829/4885PDE5A 819/4885MEN1 1039/4885
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds P2RX5, PNPO, P2RX3 APP 4242/4885PDE5A 2013/4885MEN1 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.